$UXIN
Uxin Ltd Stock $uxin

$uxin Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 20-F Financial Statement

#000095017023042446 Filed on August 14, 2023

Income Statement

Concept	2023 Q1	2023	2022 Q1
Revenue	$343.8M	$299.8M	$505.7M
YoY Change	-32.02%	-81.67%	158.1%
Cost Of Revenue	$336.0M	$296.1M	$504.6M
YoY Change	-33.42%	-81.36%	169.92%
Gross Profit	$7.802M	$3.705M	$1.119M
YoY Change	597.23%	-92.24%	-87.56%
Gross Profit Margin	2.27%	1.24%	0.22%
Selling, General & Admin	$90.70M	$58.36M	$108.6M
YoY Change	-16.45%	-84.36%	5.43%
% of Gross Profit	1162.52%	1575.25%	9701.43%
Research & Development	$9.329M	$5.490M	$8.438M
YoY Change	10.56%	-84.83%	-41.19%
% of Gross Profit	119.57%	148.18%	754.07%
Depreciation & Amortization		$13.40M	$15.98M
YoY Change		-54.83%
% of Gross Profit		361.67%	1428.06%
Operating Expenses	$65.21M	$65.87M	$110.6M
YoY Change	-41.05%	-79.84%	4.0%
Operating Profit	-$57.40M	-$51.97M	-$109.5M
YoY Change	-47.58%	-81.37%	12.47%
Interest Expense	-$5.408M	$3.093M	-$5.891M
YoY Change	-8.2%	-106.6%	-83.67%
% of Operating Profit
Other Income/Expense, Net	-$16.90M	$235.7M	$476.4M
YoY Change	-103.55%	29.11%	76621.42%
Pretax Income	-$79.72M	-$21.43M	$361.1M
YoY Change	-122.08%	-85.05%	-371.86%
Income Tax	$81.00K	$366.0K	$223.0K
% Of Pretax Income			0.06%
Net Earnings	-$835.4M	-$19.97M	$360.8M
YoY Change	-331.53%	-86.06%	-371.68%
Net Earnings / Revenue	-243.01%	-6.66%	71.34%
Basic Earnings Per Share		-$0.66
Diluted Earnings Per Share	-$0.54	-$0.66	$303.7K
COMMON SHARES
Basic Shares Outstanding		1.345B
Diluted Shares Outstanding		1.345B

Balance Sheet

Concept	2023 Q1	2023	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$92.71M	$92.71M	$128.0M
YoY Change	-27.58%	-27.58%	-33.53%
Cash & Equivalents	$92.70M	$92.71M	$128.0M
Short-Term Investments
Other Short-Term Assets	$857.0K	$62.01M	$98.29M
YoY Change	-99.13%	-36.91%	-34.01%
Inventory	$110.9M	$110.9M	$426.3M
Prepaid Expenses
Receivables	$115.0K	$790.0K	$868.0K
Other Receivables	$15.35M	$15.35M	$220.9M
Total Short-Term Assets	$41.03M	$281.7M	$874.3M
YoY Change	-95.31%	-67.78%	4.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$63.73M	$148.2M	$64.11M
YoY Change	-0.61%	131.13%	-15.79%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$5.951M	$288.7M	$288.8M
YoY Change	-97.94%	-0.02%	0.11%
Other Assets	$0.00	$0.00	$24.00M
YoY Change	-100.0%	-100.0%	-33.33%
Total Long-Term Assets	$63.62M	$436.9M	$376.9M
YoY Change	-83.12%	15.93%	-5.92%
TOTAL ASSETS
Total Short-Term Assets	$41.03M	$281.7M	$874.3M
Total Long-Term Assets	$63.62M	$436.9M	$376.9M
Total Assets	$104.6M	$718.6M	$1.251B
YoY Change	-91.64%	-42.56%	1.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.75M	$80.67M	$92.53M
YoY Change	-87.31%	-12.82%	-8.57%
Accrued Expenses	$344.5M	$150.8M	$437.1M
YoY Change	-21.18%	-65.5%	3649.42%
Deferred Revenue	$13.91M		$18.05M
YoY Change	-22.94%
Short-Term Debt	$2.912M	$20.00M	$0.00
YoY Change
Long-Term Debt Due	$214.6M	$214.6M	$388.4M
YoY Change	-44.74%	-44.74%	157.42%
Total Short-Term Liabilities	$87.94M	$603.9M	$1.299B
YoY Change	-93.23%	-53.5%	13.2%
LONG-TERM LIABILITIES
Long-Term Debt	$42.51M	$615.1M	$925.3M
YoY Change	-95.41%	-33.53%	-54.82%
Other Long-Term Liabilities	$77.46M	$77.46M	$10.87M
YoY Change	612.88%	612.88%	-68.38%
Total Long-Term Liabilities	$100.8M	$692.5M	$936.2M
YoY Change	-89.23%	-26.02%	-55.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$87.94M	$603.9M	$1.299B
Total Long-Term Liabilities	$100.8M	$692.5M	$936.2M
Total Liabilities	$188.8M	$1.296B	$2.235B
YoY Change	-91.55%	-41.99%	-30.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.90B		-$16.05B
YoY Change	5.27%
Common Stock	$2.250B		$14.25B
YoY Change	-84.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$185.4M	-$577.6M	-$983.4M
YoY Change
Total Liabilities & Shareholders Equity	$104.6M	$718.6M	$1.251B
YoY Change	-91.64%	-42.56%	1.43%

Cashflow Statement

Concept	2023 Q1	2023	2022 Q1
OPERATING ACTIVITIES
Net Income	-$835.4M	-$19.97M	$360.8M
YoY Change	-331.53%	-86.06%	-371.68%
Depreciation, Depletion And Amortization		$13.40M	$15.98M
YoY Change		-54.83%
Cash From Operating Activities		-$251.1M	-$294.6M
YoY Change		-70.28%
INVESTING ACTIVITIES
Capital Expenditures		$4.834M	-$13.66M
YoY Change		-125.91%
Acquisitions
YoY Change
Other Investing Activities		$1.164M	$249.0K
YoY Change		-38.25%
Cash From Investing Activities		-$4.664M	-$13.41M
YoY Change		-72.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$887.3M
YoY Change
Debt Paid & Issued, Net		$51.90M
YoY Change		-12.03%
Cash From Financing Activities		34.94M	212.5M
YoY Change		-95.43%
NET CHANGE
Cash From Operating Activities		-251.1M	-294.6M
Cash From Investing Activities		-4.664M	-13.41M
Cash From Financing Activities		34.94M	212.5M
Net Change In Cash		-6.256M	-95.51M
YoY Change		-93.57%
FREE CASH FLOW
Cash From Operating Activities		-$251.1M	-$294.6M
Capital Expenditures		$4.834M	-$13.66M
Free Cash Flow		-$255.9M	-$280.9M
YoY Change		-69.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001729173
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://www.xin.com/20230331#ForwardContractAssetsCurrent
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38527
CY2023	dei	Entity Registrant Name EntityRegistrantName	Uxin Limited
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	21/F, Donghuang Building
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	No. 16 Guangshun South Avenue
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Chaoyang District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100102
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1424
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers Zhong Tian LLP
CY2023	dei	Auditor Location AuditorLocation	Shanghai, the People’s Republic of China
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	128021000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92713000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13500000
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	8276000
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	618000
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	90000
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	832000
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	790000
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	115000
CY2022Q1	us-gaap	Inventory Net InventoryNet	426257000
CY2023Q1	us-gaap	Inventory Net InventoryNet	110893000
CY2023Q1	us-gaap	Inventory Net InventoryNet	16147000
CY2022Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	324371000
CY2023Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	10337000
CY2022Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	54888000
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	30251000
CY2023Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	26541000
CY2022Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	166006000
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15345000
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2234000
CY2022Q1	uxin	Forward Contract Assets Current ForwardContractAssetsCurrent	36000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90012000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61390000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8939000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	874328000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	281749000
CY2023Q1	us-gaap	Assets Current AssetsCurrent	41025000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34531000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	63725000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9279000
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	288756000
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	288712000
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	42040000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24000000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29584000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84461000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12298000
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	376871000
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	436898000
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	63617000
CY2022Q1	us-gaap	Assets Assets	1251199000
CY2023Q1	us-gaap	Assets Assets	718647000
CY2023Q1	us-gaap	Assets Assets	104642000
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	92534000
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	80668000
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11746000
CY2022Q1	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	179000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	674333000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	344502000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	50163000
CY2022Q1	uxin	Warrant Liabilities Current WarrantLiabilitiesCurrent	196390000
CY2023Q1	uxin	Warrant Liabilities Current WarrantLiabilitiesCurrent	8000
CY2023Q1	uxin	Warrant Liabilities Current WarrantLiabilitiesCurrent	1000
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	20000000
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	2912000
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	233000000
CY2022Q1	uxin	Current Portion Of Long Term Debt CurrentPortionOfLongTermDebt	102206000
CY2023Q1	uxin	Current Portion Of Long Term Debt CurrentPortionOfLongTermDebt	158736000
CY2023Q1	uxin	Current Portion Of Long Term Debt CurrentPortionOfLongTermDebt	23114000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1298642000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	603914000
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	87936000
CY2022Q1	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Noncurrent LiabilitiesOfBusinessTransferredUnderContractualArrangementNoncurrent	107642000
CY2023Q1	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Noncurrent LiabilitiesOfBusinessTransferredUnderContractualArrangementNoncurrent	58559000
CY2023Q1	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Noncurrent LiabilitiesOfBusinessTransferredUnderContractualArrangementNoncurrent	8527000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10866000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77462000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11279000
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	291950000
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	42511000
CY2022Q1	uxin	Non Current Portion Of Long Term Debt NonCurrentPortionOfLongTermDebt	817648000
CY2023Q1	uxin	Non Current Portion Of Long Term Debt NonCurrentPortionOfLongTermDebt	264560000
CY2023Q1	uxin	Non Current Portion Of Long Term Debt NonCurrentPortionOfLongTermDebt	38523000
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	936156000
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	692531000
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	100840000
CY2022Q1	us-gaap	Liabilities Liabilities	2234798000
CY2023Q1	us-gaap	Liabilities Liabilities	1296445000
CY2023Q1	us-gaap	Liabilities Liabilities	188776000
CY2022Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1000000000
CY2023Q1	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	1720000000
CY2022Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	400524323
CY2022Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	400524323
CY2023Q1	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1151221338
CY2023Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1151221338
CY2022Q1	uxin	Temporary Equity Senior Convertible Preferred Shares TemporaryEquitySeniorConvertiblePreferredShares	526484000
CY2023Q1	uxin	Temporary Equity Senior Convertible Preferred Shares TemporaryEquitySeniorConvertiblePreferredShares	1245721000
CY2023Q1	uxin	Temporary Equity Senior Convertible Preferred Shares TemporaryEquitySeniorConvertiblePreferredShares	181391000
CY2023Q1	us-gaap	Preferred Stock Shares Subscribed But Unissued Subscriptions Receivable PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable	550074000
CY2023Q1	us-gaap	Preferred Stock Shares Subscribed But Unissued Subscriptions Receivable PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable	80097000
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	526484000
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	695647000
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	101294000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9000000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8280000000
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	782000
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	806000
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	117000
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	14254109000
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	15451803000
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2249957000
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	288461000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	220185000
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	32061000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16053272000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16946064000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2467538000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-1509920000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1273270000
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-185403000
CY2022Q1	us-gaap	Minority Interest MinorityInterest	-163000
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-175000
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-25000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1510083000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1273445000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-185428000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1251199000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	718647000
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104642000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	657408000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1636116000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2059241000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299849000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	673711000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1588398000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	2033797000
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	296144000
CY2021	us-gaap	Gross Profit GrossProfit	-16303000
CY2022	us-gaap	Gross Profit GrossProfit	47718000
CY2023	us-gaap	Gross Profit GrossProfit	25444000
CY2023	us-gaap	Gross Profit GrossProfit	3705000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	339013000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	222139000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	236307000
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34409000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	74137000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36200000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	37704000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5490000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	277925000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	151024000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	164505000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23954000
CY2021	uxin	Provision For Reversal Of Loan Lease And Other Losses Operating ProvisionForReversalOfLoanLeaseAndOtherLossesOperating	91593000
CY2022	uxin	Provision For Reversal Of Loan Lease And Other Losses Operating ProvisionForReversalOfLoanLeaseAndOtherLossesOperating	-687000
CY2023	uxin	Provision For Reversal Of Loan Lease And Other Losses Operating ProvisionForReversalOfLoanLeaseAndOtherLossesOperating	13844000
CY2023	uxin	Provision For Reversal Of Loan Lease And Other Losses Operating ProvisionForReversalOfLoanLeaseAndOtherLossesOperating	2016000
CY2021	us-gaap	Operating Expenses OperatingExpenses	782668000
CY2022	us-gaap	Operating Expenses OperatingExpenses	408676000
CY2023	us-gaap	Operating Expenses OperatingExpenses	452360000
CY2023	us-gaap	Operating Expenses OperatingExpenses	65869000
CY2021	uxin	Operating Income Other OperatingIncomeOther	246346000
CY2022	uxin	Operating Income Other OperatingIncomeOther	82017000
CY2023	uxin	Operating Income Other OperatingIncomeOther	69990000
CY2023	uxin	Operating Income Other OperatingIncomeOther	10191000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-552625000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-278941000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-356926000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-51973000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	45140000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	3660000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	603000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	88000
CY2021	us-gaap	Interest Expense InterestExpense	95953000
CY2022	us-gaap	Interest Expense InterestExpense	41222000
CY2023	us-gaap	Interest Expense InterestExpense	21243000
CY2023	us-gaap	Interest Expense InterestExpense	3093000
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	15672000
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5227000
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	17088000
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2488000
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	7890000
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	8925000
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	24153000
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3517000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-15887000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9336000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2457000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-358000
CY2022	uxin	Fair Value Impact Of Issuance Of Senior Convertible Preferred Shares FairValueImpactOfIssuanceOfSeniorConvertiblePreferredShares	186231000
CY2023	uxin	Fair Value Impact Of Issuance Of Senior Convertible Preferred Shares FairValueImpactOfIssuanceOfSeniorConvertiblePreferredShares	242733000
CY2023	uxin	Fair Value Impact Of Issuance Of Senior Convertible Preferred Shares FairValueImpactOfIssuanceOfSeniorConvertiblePreferredShares	35345000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2778000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-405000
CY2021	uxin	Inducement Charge Of Convertible Notes InducementChargeOfConvertibleNotes	121056000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-732599000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-143306000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-147133000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-21425000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	245000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	366000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53000
CY2023	uxin	Dividend From Long Term Investment DividendFromLongTermInvestment	10374000
CY2023	uxin	Dividend From Long Term Investment DividendFromLongTermInvestment	1510000
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15657000
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	328000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-44000
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-716975000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-143223000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-137169000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-19974000
CY2021	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-9000
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-12000
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-2000
CY2021	uxin	Income Loss From Continuing Operations Including Preferred Stock Dividends IncomeLossFromContinuingOperationsIncludingPreferredStockDividends	-716966000
CY2022	uxin	Income Loss From Continuing Operations Including Preferred Stock Dividends IncomeLossFromContinuingOperationsIncludingPreferredStockDividends	-143223000
CY2023	uxin	Income Loss From Continuing Operations Including Preferred Stock Dividends IncomeLossFromContinuingOperationsIncludingPreferredStockDividends	-137157000
CY2023	uxin	Income Loss From Continuing Operations Including Preferred Stock Dividends IncomeLossFromContinuingOperationsIncludingPreferredStockDividends	-19972000
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-755635000
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-110029000
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-716966000
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-143223000
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-892792000
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-130001000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	295744000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	295744000
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	295744000
CY2021	us-gaap	Profit Loss ProfitLoss	-421231000
CY2022	us-gaap	Profit Loss ProfitLoss	-143223000
CY2023	us-gaap	Profit Loss ProfitLoss	-137169000
CY2023	us-gaap	Profit Loss ProfitLoss	-19974000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-421222000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-143223000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-137157000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-19972000
CY2023	uxin	Temporary Equity Contribution From Preferred Shareholders TemporaryEquityContributionFromPreferredShareholders	-755635000
CY2023	uxin	Temporary Equity Contribution From Preferred Shareholders TemporaryEquityContributionFromPreferredShareholders	-110029000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-421222000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-143223000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-892792000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-130001000
CY2021	us-gaap	Profit Loss ProfitLoss	-421231000
CY2022	us-gaap	Profit Loss ProfitLoss	-143223000
CY2023	us-gaap	Profit Loss ProfitLoss	-137169000
CY2023	us-gaap	Profit Loss ProfitLoss	-19974000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	110983000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	70714000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-68276000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-9942000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-310248000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-72509000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-205445000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-29916000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-9000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-12000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-310239000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-72509000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-205433000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29914000
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-716966000
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-143223000
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-892792000
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-130001000
CY2021	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	295744000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-421222000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-143223000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-892792000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-130001000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1100650208
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1168419750
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1344536565
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1344536565
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1330913033
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1354506021
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1344536565
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1344536565
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.65
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.66
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.27
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.65
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.07
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.66
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.22
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2344647000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	110983000
CY2021	us-gaap	Profit Loss ProfitLoss	-421231000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1911000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	169499000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-19122000
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	506752000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1995855000
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1995855000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	70714000
CY2022	us-gaap	Profit Loss ProfitLoss	-143223000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15713000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	26534000
CY2022	uxin	Gain Loss On Restructuring Of Debt From Equity Holders Of Company GainLossOnRestructuringOfDebtFromEquityHoldersOfCompany	61018000
CY2022	uxin	Adjustments To Additional Paid In Capital Contribution From Shareholder AdjustmentsToAdditionalPaidInCapitalContributionFromShareholder	8000000
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	447016000
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1510083000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1510083000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-68276000
CY2023	us-gaap	Profit Loss ProfitLoss	-137169000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	43000
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	47313000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	394727000
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1273445000
CY2021	us-gaap	Profit Loss ProfitLoss	-421231000
CY2022	us-gaap	Profit Loss ProfitLoss	-143223000
CY2023	us-gaap	Profit Loss ProfitLoss	-137169000
CY2023	us-gaap	Profit Loss ProfitLoss	-19974000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	-19122000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	26534000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	47313000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	6890000
CY2021	us-gaap	Depreciation Depreciation	46391000
CY2022	us-gaap	Depreciation Depreciation	14265000
CY2023	us-gaap	Depreciation Depreciation	13355000
CY2023	us-gaap	Depreciation Depreciation	1945000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	111000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	27000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	10950000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	15373000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	17489000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2547000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-6568000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1494000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-670000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-98000
CY2021	uxin	Equity In Income Loss Of Affiliates EquityInIncomeLossOfAffiliates	15657000
CY2022	uxin	Equity In Income Loss Of Affiliates EquityInIncomeLossOfAffiliates	328000
CY2023	uxin	Equity In Income Loss Of Affiliates EquityInIncomeLossOfAffiliates	-44000
CY2023	uxin	Equity In Income Loss Of Affiliates EquityInIncomeLossOfAffiliates	-6000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	16279000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	14223000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	-12003000
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	-1748000
CY2021	uxin	Provision For Reversal Of Credit Losses ProvisionForReversalOfCreditLosses	91593000
CY2022	uxin	Provision For Reversal Of Credit Losses ProvisionForReversalOfCreditLosses	-687000
CY2023	uxin	Provision For Reversal Of Credit Losses ProvisionForReversalOfCreditLosses	13844000
CY2023	uxin	Provision For Reversal Of Credit Losses ProvisionForReversalOfCreditLosses	2016000
CY2021	uxin	Guarantee Income GuaranteeIncome	207825000
CY2022	uxin	Guarantee Income GuaranteeIncome	126000
CY2023	uxin	Guarantee Income GuaranteeIncome	46000
CY2023	uxin	Guarantee Income GuaranteeIncome	7000
CY2021	uxin	Discounting Impact Of Non Current Consideration Payables DiscountingImpactOfNonCurrentConsiderationPayables	30898000
CY2022	uxin	Discounting Impact Of Non Current Consideration Payables DiscountingImpactOfNonCurrentConsiderationPayables	-11986000
CY2023	uxin	Discounting Impact Of Non Current Consideration Payables DiscountingImpactOfNonCurrentConsiderationPayables	-8486000
CY2023	uxin	Discounting Impact Of Non Current Consideration Payables DiscountingImpactOfNonCurrentConsiderationPayables	-1236000
CY2022	uxin	Fair Value Impact Of The Issuance Of Senior Convertible Preferred Shares FairValueImpactOfTheIssuanceOfSeniorConvertiblePreferredShares	186231000
CY2023	uxin	Fair Value Impact Of The Issuance Of Senior Convertible Preferred Shares FairValueImpactOfTheIssuanceOfSeniorConvertiblePreferredShares	242733000
CY2023	uxin	Fair Value Impact Of The Issuance Of Senior Convertible Preferred Shares FairValueImpactOfTheIssuanceOfSeniorConvertiblePreferredShares	35345000
CY2022	uxin	Gains From Waiver Of Operating Payables GainsFromWaiverOfOperatingPayables	73747000
CY2023	uxin	Gains From Waiver Of Operating Payables GainsFromWaiverOfOperatingPayables	70500000
CY2023	uxin	Gains From Waiver Of Operating Payables GainsFromWaiverOfOperatingPayables	10266000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2778000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-405000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9541000
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	420000000
CY2021	uxin	Transaction Gain From Divestiture Transactions Net TransactionGainFromDivestitureTransactionsNet	721211000
CY2021	uxin	Inducement Charge InducementCharge	121056000
CY2021	uxin	Increase Decrease In Receivables Prepaid Expense And Other Assets IncreaseDecreaseInReceivablesPrepaidExpenseAndOtherAssets	-48250000
CY2022	uxin	Increase Decrease In Receivables Prepaid Expense And Other Assets IncreaseDecreaseInReceivablesPrepaidExpenseAndOtherAssets	-51824000
CY2023	uxin	Increase Decrease In Receivables Prepaid Expense And Other Assets IncreaseDecreaseInReceivablesPrepaidExpenseAndOtherAssets	-28268000
CY2023	uxin	Increase Decrease In Receivables Prepaid Expense And Other Assets IncreaseDecreaseInReceivablesPrepaidExpenseAndOtherAssets	-4116000
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-36664000
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-3817000
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	69434000
CY2021	uxin	Increase Decrease In Loan Recognized As Result Of Payment Under Guarantee Net Current IncreaseDecreaseInLoanRecognizedAsResultOfPaymentUnderGuaranteeNetCurrent	-134380000
CY2022	uxin	Increase Decrease In Loan Recognized As Result Of Payment Under Guarantee Net Current IncreaseDecreaseInLoanRecognizedAsResultOfPaymentUnderGuaranteeNetCurrent	-148708000
CY2023	uxin	Increase Decrease In Loan Recognized As Result Of Payment Under Guarantee Net Current IncreaseDecreaseInLoanRecognizedAsResultOfPaymentUnderGuaranteeNetCurrent	-14330000
CY2023	uxin	Increase Decrease In Loan Recognized As Result Of Payment Under Guarantee Net Current IncreaseDecreaseInLoanRecognizedAsResultOfPaymentUnderGuaranteeNetCurrent	-2087000
CY2021	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-83537000
CY2021	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-8510000
CY2022	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	-10000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	75552000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	372120000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-327083000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47627000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-354669000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-266922000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-204786000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-29819000
CY2021	uxin	Increase Decrease In Deposit Of Interests From Consumers And Payable To Financing Partners Current IncreaseDecreaseInDepositOfInterestsFromConsumersAndPayableToFinancingPartnersCurrent	-18032000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-27052000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5247000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4140000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-603000
CY2021	uxin	Consideration Payable To Webank Net Of Discounting Impact ConsiderationPayableToWebankNetOfDiscountingImpact	334323000
CY2022	uxin	Consideration Payable To Webank Net Of Discounting Impact ConsiderationPayableToWebankNetOfDiscountingImpact	81604000
CY2023	uxin	Consideration Payable To Webank Net Of Discounting Impact ConsiderationPayableToWebankNetOfDiscountingImpact	53423000
CY2023	uxin	Consideration Payable To Webank Net Of Discounting Impact ConsiderationPayableToWebankNetOfDiscountingImpact	7779000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1122308000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-844962000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-251140000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36568000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	13357000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1885000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	494000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	72000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	413000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18654000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33196000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4834000
CY2021	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	130000000
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	670000
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	98000
CY2021	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	300072000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	443016000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16769000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32032000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4664000
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	313000000
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	45576000
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	41094000
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	79560000
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	234050000
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	34080000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	58956000
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	51882000
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7555000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1912000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	15713000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	42000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	169499000
CY2022	uxin	Proceeds From The Issuance Of Senior Convertible Preferred Shares In Conjunction With Warrants ProceedsFromTheIssuanceOfSeniorConvertiblePreferredSharesInConjunctionWithWarrants	887225000
CY2023	uxin	Proceeds From The Issuance Of Senior Convertible Preferred Shares In Conjunction With Warrants ProceedsFromTheIssuanceOfSeniorConvertiblePreferredSharesInConjunctionWithWarrants	212875000
CY2023	uxin	Proceeds From The Issuance Of Senior Convertible Preferred Shares In Conjunction With Warrants ProceedsFromTheIssuanceOfSeniorConvertiblePreferredSharesInConjunctionWithWarrants	30997000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	130317000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	764422000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	239985000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	34944000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-14741000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-113000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	221000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-563716000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-97422000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42966000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6256000
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	797435000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233719000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136297000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19846000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233719000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136297000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93331000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13590000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	22000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	179000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	222000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	32000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	19717000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5111000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	58945000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	8583000
CY2021	uxin	Unreceived Disposal Consideration UnreceivedDisposalConsideration	129307000
CY2022	uxin	Net Settlement Of Long Term Debt With Unreceived Disposal Consideration NetSettlementOfLongTermDebtWithUnreceivedDisposalConsideration	45350000
CY2023	uxin	Conversion Of Long Term Debt Into Equity ConversionOfLongTermDebtIntoEquity	511318000
CY2023	uxin	Conversion Of Long Term Debt Into Equity ConversionOfLongTermDebtIntoEquity	74454000
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16900000000
CY2023Q1	uxin	Current Liabilities Exceeded Current Assets CurrentLiabilitiesExceededCurrentAssets	322200000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92700000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-251100000
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	50000000
CY2023Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	7300000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">2.4 Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets, long-lived assets and liabilities at the dates of the financial statements and the reported amount of revenues and expenses during the reporting periods. On an ongoing basis, the Company’s management reviews these estimates based on information that is currently available. Changes in facts and circumstances may cause the Company to revise its estimates. Accounting estimates reflected in the Group’s consolidated financial statements include, but are not limited to, the fair value of senior convertible preferred shares, warrant liabilities,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">forward contracts, share-based compensation arrangements, fair value of the long-term investment, provision for credit losses for loans recognized as a result of payments under guarantees and other receivables, the useful lives of property, equipment and software, incremental borrowing rate applied in lease accounting, inventory provision and valuation allowances for deferred tax assets. Given that changes in circumstances, facts and experience may cause the Group to revise its estimates, actual results could differ from those estimates.</span></p>
CY2023Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.8676
CY2022Q1	us-gaap	Inventory Net InventoryNet	426300000
CY2023Q1	us-gaap	Inventory Net InventoryNet	110900000
CY2021Q1	uxin	Inventory Provision InventoryProvision	4700000
CY2022Q1	uxin	Inventory Provision InventoryProvision	14200000
CY2023Q1	uxin	Inventory Provision InventoryProvision	30200000
CY2023	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">2.11 Guarantee liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Before the three months ended December 31, 2019, the third-party financing partners offered financing solutions to the buyers (the “Borrowers”) and the Company was required to provide a guarantee in the event of Borrower default. The balances as of March 31, 2022 represent the Company’s remaining guarantee obligations in relation to the historically facilitated loans.</span></p>
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4100000
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2300000
CY2023	uxin	Revenue Remaining Performance Obligation Expected Percentage RevenueRemainingPerformanceObligationExpectedPercentage	1
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021	us-gaap	Advertising Expense AdvertisingExpense	128900000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	58700000
CY2023	us-gaap	Advertising Expense AdvertisingExpense	46900000
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1770000
CY2023	uxin	Allowance For Doubtful Notes Loans And Financing Receivable Write Offs AllowanceForDoubtfulNotesLoansAndFinancingReceivableWriteOffs	308847000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	6957000
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2190575000
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1182609000
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	324371000
CY2021	uxin	Financing Receivable Allowance For Credit Loss Additional Guarantees Increase FinancingReceivableAllowanceForCreditLossAdditionalGuaranteesIncrease	68578000
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-29272000
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-94000
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1770000
CY2021	uxin	Allowance For Doubtful Notes Loans And Financing Receivable Write Offs AllowanceForDoubtfulNotesLoansAndFinancingReceivableWriteOffs	252508000
CY2022	uxin	Allowance For Doubtful Notes Loans And Financing Receivable Write Offs AllowanceForDoubtfulNotesLoansAndFinancingReceivableWriteOffs	13093000
CY2023	uxin	Allowance For Doubtful Notes Loans And Financing Receivable Write Offs AllowanceForDoubtfulNotesLoansAndFinancingReceivableWriteOffs	308847000
CY2021	uxin	Financing Receivable Allowance For Credit Losses Buyouts FinancingReceivableAllowanceForCreditLossesBuyouts	845305000
CY2022	uxin	Financing Receivable Allowance For Credit Losses Buyouts FinancingReceivableAllowanceForCreditLossesBuyouts	821496000
CY2021	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	8003000
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	23743000
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	6957000
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	1182609000
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	324371000
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10337000
CY2022Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	324371000
CY2022Q1	us-gaap	Security Deposit SecurityDeposit	39697000
CY2023Q1	us-gaap	Allowance For Notes And Loans Receivable Current AllowanceForNotesAndLoansReceivableCurrent	10337000
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	26418000
CY2022Q1	us-gaap	Due From Employees Current DueFromEmployeesCurrent	15742000
CY2023Q1	us-gaap	Due From Employees Current DueFromEmployeesCurrent	13890000
CY2022Q1	uxin	Unreceived Disposal Considerations UnreceivedDisposalConsiderations	93988000
CY2022Q1	us-gaap	Other Receivables OtherReceivables	46830000
CY2023Q1	us-gaap	Other Receivables OtherReceivables	1578000
CY2022Q1	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	196257000
CY2023Q1	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	41886000
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	30251000
CY2023Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	26541000
CY2022Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	166006000
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15345000
CY2022Q3	uxin	Unreceivedconsideration Unreceivedconsideration	84300000
CY2020Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	51666000
CY2021Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	20980000
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	30251000
CY2021	uxin	Provision For Doubtful Accounts Other Receivables ProvisionForDoubtfulAccountsOtherReceivables	-1104000
CY2022	uxin	Provision For Doubtful Accounts Other Receivables ProvisionForDoubtfulAccountsOtherReceivables	-3494000
CY2023	uxin	Provision For Doubtful Accounts Other Receivables ProvisionForDoubtfulAccountsOtherReceivables	-12400000
CY2021	uxin	Allowance For Other Receivables Write Offs AllowanceForOtherReceivablesWriteOffs	31790000
CY2022	uxin	Allowance For Other Receivables Write Offs AllowanceForOtherReceivablesWriteOffs	679000
CY2023	uxin	Allowance For Other Receivables Write Offs AllowanceForOtherReceivablesWriteOffs	16110000
CY2022Q1	us-gaap	Due From Other Related Parties DueFromOtherRelatedParties	6456000
CY2021Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	20980000
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	30251000
CY2023Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	26541000
CY2022Q1	us-gaap	Prepaid Taxes PrepaidTaxes	54728000
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	54601000
CY2022Q1	us-gaap	Prepaid Rent PrepaidRent	2469000
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	2537000
CY2022Q1	uxin	Prepaid Marketing Expense PrepaidMarketingExpense	7877000
CY2023Q1	uxin	Prepaid Marketing Expense PrepaidMarketingExpense	2009000
CY2022Q1	uxin	Prepaid Consulting And Professional Service Fees PrepaidConsultingAndProfessionalServiceFees	5383000
CY2023Q1	uxin	Prepaid Consulting And Professional Service Fees PrepaidConsultingAndProfessionalServiceFees	1247000
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	4973000
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	139000
CY2022Q1	uxin	Prepaid Financial Advisory Service Fee PrepaidFinancialAdvisoryServiceFee	12000000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2582000
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	857000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90012000
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61390000
CY2022Q1	uxin	Aggregate Amount Of Prepaid Financial Advisory Service Fee AggregateAmountOfPrepaidFinancialAdvisoryServiceFee	60000000.0
CY2022	uxin	Aggregate Amount Of Prepaid Financial Advisory Service Fee Term Period AggregateAmountOfPrepaidFinancialAdvisoryServiceFeeTermPeriod	P5Y
CY2022Q1	us-gaap	Guarantee Obligations Current Carrying Value GuaranteeObligationsCurrentCarryingValue	179000
CY2022Q3	uxin	Prepaid Financial Advisory Service Fee PrepaidFinancialAdvisoryServiceFee	12000000.0
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	268882000
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	306421000
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	234351000
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	242696000
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34531000
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	63725000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	46400000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14300000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13400000
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	5995000
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	5951000
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	288756000
CY2023Q1	us-gaap	Long Term Investments LongTermInvestments	288712000
CY2022Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	233000000
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	311950000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	233000000.0
CY2022Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-12-15
CY2022Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.050
CY2023Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.050
CY2023Q1	uxin	Liabilities Of Business Transferred Under Contractual Arrangement LiabilitiesOfBusinessTransferredUnderContractualArrangement	114446000
CY2022Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	53162000
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	55887000
CY2022Q1	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Noncurrent LiabilitiesOfBusinessTransferredUnderContractualArrangementNoncurrent	107642000
CY2023Q1	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Noncurrent LiabilitiesOfBusinessTransferredUnderContractualArrangementNoncurrent	58559000
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	68720000
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	66010000
CY2022Q1	uxin	Accrued Service Fee For It And Other Professional Support AccruedServiceFeeForItAndOtherProfessionalSupport	53285000
CY2023Q1	uxin	Accrued Service Fee For It And Other Professional Support AccruedServiceFeeForItAndOtherProfessionalSupport	65514000
CY2022Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	53162000
CY2023Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	55887000
CY2022Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	60014000
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	40162000
CY2022Q1	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	268455000
CY2023Q1	us-gaap	Accrued Advertising Current AccruedAdvertisingCurrent	34942000
CY2022Q1	uxin	Accrued Service Fee For Transaction Support AccruedServiceFeeForTransactionSupport	39132000
CY2023Q1	uxin	Accrued Service Fee For Transaction Support AccruedServiceFeeForTransactionSupport	24386000
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18049000
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	13909000
CY2022Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	13815000
CY2023Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	13834000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10994000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7667000
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	50969000
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	4457000
CY2022Q1	uxin	Accrued Legal Proceedings And Litigations AccruedLegalProceedingsAndLitigations	420000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	37318000
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17734000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	674333000
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	344502000
CY2023	uxin	Payment Of Accrued Advertising Expense PaymentOfAccruedAdvertisingExpense	100000000.0
CY2023	uxin	Accrued Advertising Expenses Waived After Full Payment AccruedAdvertisingExpensesWaivedAfterFullPayment	56100000
CY2022Q1	uxin	Liabilities Of Business Transferred Under Contractual Arrangement LiabilitiesOfBusinessTransferredUnderContractualArrangement	160804000
CY2022Q1	uxin	Current Portion Of Long Term Debt CurrentPortionOfLongTermDebt	102206000
CY2023Q1	uxin	Current Portion Of Long Term Debt CurrentPortionOfLongTermDebt	158736000
CY2022Q1	uxin	Non Current Portion Of Long Term Debt NonCurrentPortionOfLongTermDebt	817648000
CY2023Q1	uxin	Non Current Portion Of Long Term Debt NonCurrentPortionOfLongTermDebt	264560000
CY2022Q1	uxin	Long Term Debt Net LongTermDebtNet	919854000
CY2023Q1	uxin	Long Term Debt Net LongTermDebtNet	423296000
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	59000000.0
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	51900000
CY2021	uxin	Waiver Of Operating Payables Income WaiverOfOperatingPayablesIncome	2010000
CY2022	uxin	Waiver Of Operating Payables Income WaiverOfOperatingPayablesIncome	73747000
CY2023	uxin	Waiver Of Operating Payables Income WaiverOfOperatingPayablesIncome	70500000
CY2021	uxin	Government Grant Income GovernmentGrantIncome	15392000
CY2022	uxin	Government Grant Income GovernmentGrantIncome	1895000
CY2023	uxin	Government Grant Income GovernmentGrantIncome	5252000
CY2021	uxin	Guarantee Income GuaranteeIncome	207825000
CY2022	uxin	Guarantee Income GuaranteeIncome	126000
CY2023	uxin	Guarantee Income GuaranteeIncome	46000
CY2021	uxin	Sale Of Loan Recognized As Result Of Payment Under Guarantee Without Recourse Income SaleOfLoanRecognizedAsResultOfPaymentUnderGuaranteeWithoutRecourseIncome	21119000
CY2022	uxin	Sale Of Loan Recognized As Result Of Payment Under Guarantee Without Recourse Income SaleOfLoanRecognizedAsResultOfPaymentUnderGuaranteeWithoutRecourseIncome	26279000
CY2022	uxin	Transfer Out Of Unused Vat Input Deductible TransferOutOfUnusedVatInputDeductible	20030000
CY2023	uxin	Other Operating Income Others OtherOperatingIncomeOthers	-5808000
CY2021	us-gaap	Other Operating Income OtherOperatingIncome	246346000
CY2022	us-gaap	Other Operating Income OtherOperatingIncome	82017000
CY2023	us-gaap	Other Operating Income OtherOperatingIncome	69990000
CY2023	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	120400000
CY2022	uxin	Waver Of Other Payables WaverOfOtherPayables	64300000
CY2023	uxin	Increase Of Waiver Of Operating Payables Income IncreaseOfWaiverOfOperatingPayablesIncome	56100000
CY2021	uxin	Gain From Wavier Of Settlement Of Long Aged Payables GainFromWavierOfSettlementOfLongAgedPayables	2000000.0
CY2022	uxin	Gain From Wavier Of Settlement Of Long Aged Payables GainFromWavierOfSettlementOfLongAgedPayables	9400000
CY2023	uxin	Gain From Wavier Of Settlement Of Long Aged Payables GainFromWavierOfSettlementOfLongAgedPayables	14400000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	29584000
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84461000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	10994000
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7667000
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10866000
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77462000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	21860000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	85129000
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y7M20D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0519
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0513
CY2021	us-gaap	Lease Cost LeaseCost	36300000
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11700000
CY2022	us-gaap	Lease Cost LeaseCost	19800000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	3300000
CY2023	us-gaap	Lease Cost LeaseCost	23400000
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5900000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	13599000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	23547000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	10231000
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	46829000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	23628000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	84947000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11174000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8821000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	9263000
CY2023Q1	uxin	Lessee Operating Lease Liability Payments Due After Year Three LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree	76411000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	105669000
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20540000
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	85129000
CY2021	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	89843000
CY2022	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	351000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	33000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	245000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	366000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	245000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	366000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250
CY2021	uxin	Effective Income Tax Reconciliation Permanent Tax Adjustments EffectiveIncomeTaxReconciliationPermanentTaxAdjustments	-0.170
CY2022	uxin	Effective Income Tax Reconciliation Permanent Tax Adjustments EffectiveIncomeTaxReconciliationPermanentTaxAdjustments	-0.420
CY2023	uxin	Effective Income Tax Reconciliation Permanent Tax Adjustments EffectiveIncomeTaxReconciliationPermanentTaxAdjustments	-0.033
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.007
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.124
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.367
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.073
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.048
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.581
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.002
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.003
CY2023	uxin	Convertible Preferred Shares Redemption Adss Fails To Be Listed Or Quoted Number Of Trading Days ConvertiblePreferredSharesRedemptionAdssFailsToBeListedOrQuotedNumberOfTradingDays	5
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1449953000
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1591988000
CY2022Q1	uxin	Deferred Tax Assets Deductible Advertising Expense DeferredTaxAssetsDeductibleAdvertisingExpense	551431000
CY2023Q1	uxin	Deferred Tax Assets Deductible Advertising Expense DeferredTaxAssetsDeductibleAdvertisingExpense	582306000
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	94706000
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	13421000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2096090000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2187715000
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1974108000
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2005864000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2096090000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	31756000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	90226000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	91625000
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2005864000
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2096090000
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2187715000
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6420000000.0
CY2021Q2	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	165000000.0
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	0
CY2023	us-gaap	Dividends Dividends	0
CY2023	uxin	Temporary Equity Percentage Of Liquidation Preference On Share Issue Price TemporaryEquityPercentageOfLiquidationPreferenceOnShareIssuePrice	1.50
CY2023	uxin	Convertible Preferred Shares Redemption Adjusted Redemption Price Percentage ConvertiblePreferredSharesRedemptionAdjustedRedemptionPricePercentage	0.08
CY2023	uxin	Fair Value Impacts Of Issuance Of Senior Convertible Preferred Shares FairValueImpactsOfIssuanceOfSeniorConvertiblePreferredShares	242700000
CY2023	uxin	Fair Value Impacts Of Issuance Of Senior Convertible Preferred Shares FairValueImpactsOfIssuanceOfSeniorConvertiblePreferredShares	35300000
CY2022	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	239452000
CY2022	uxin	Fair Value Impacts On Senior Convertible Preferred Shares Recorded Upon Cash Receipt For Subscription FairValueImpactsOnSeniorConvertiblePreferredSharesRecordedUponCashReceiptForSubscription	287032000
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	526484000
CY2023	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	758252000
CY2023	uxin	Subscription Receivable On Convertible Preferred Shares From Shareholders SubscriptionReceivableOnConvertiblePreferredSharesFromShareholders	-550074000
CY2023	uxin	Fair Value Impacts On Senior Convertible Preferred Shares Recorded Upon Cash Receipt For Subscription FairValueImpactsOnSeniorConvertiblePreferredSharesRecordedUponCashReceiptForSubscription	-39015000
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	695647000
CY2022	uxin	Fair Value Impact Of Warrants FairValueImpactOfWarrants	424513000
CY2023	uxin	Fair Value Impact Of Warrants FairValueImpactOfWarrants	204687000
CY2022	uxin	Fair Value Impact Of Forward Contracts FairValueImpactOfForwardContracts	-294156000
CY2023	uxin	Fair Value Impact Of Forward Contracts FairValueImpactOfForwardContracts	38046000
CY2022	uxin	Gain From Tdr Of2024 Notes GainFromTdrOf2024Notes	55874000
CY2022	uxin	Fair Value Impact Of Issuance Of Senior Convertible Preferred Shares FairValueImpactOfIssuanceOfSeniorConvertiblePreferredShares	186231000
CY2023	uxin	Fair Value Impact Of Issuance Of Senior Convertible Preferred Shares FairValueImpactOfIssuanceOfSeniorConvertiblePreferredShares	242733000
CY2022Q1	uxin	Warrant Liabilities Fair Value WarrantLiabilitiesFairValue	196390000
CY2023Q1	uxin	Warrant Liabilities Fair Value WarrantLiabilitiesFairValue	8000
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-716975000
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-143223000
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9000000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8280000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1410826415
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1186854720
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	Each Class B ordinary share was entitled to 10 votes, while each Class A ordinary shares was entitled to one vote.
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	each ADS representing three Class A ordinary shares to each ADS representing 30 Class A ordinary shares (“the ADS Ratio Change”).
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-19122000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26534000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	47313000
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	755600000
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2022Q1	us-gaap	Derivative Assets DerivativeAssets	36000
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-137169000
CY2021	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-9000
CY2023	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-12000
CY2023	us-gaap	Preferred Stock Convertible Down Round Feature Increase Decrease In Equity Amount1 PreferredStockConvertibleDownRoundFeatureIncreaseDecreaseInEquityAmount1	-755635000
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-716966000
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-143223000
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-892792000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1100650208
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1168419750
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1344536565
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.65
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.66
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-716966000
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-143223000
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-892792000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2224660000
CY2022	uxin	Fair Value Adjustment Of Forward Contract Liability FairValueAdjustmentOfForwardContractLiability	-441088000
CY2021	uxin	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted After Adjustments NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDilutedAfterAdjustments	-716966000
CY2022	uxin	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted After Adjustments NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDilutedAfterAdjustments	-2808971000
CY2023	uxin	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted After Adjustments NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDilutedAfterAdjustments	-892792000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1100650208
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1168419750
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1344536565
CY2022	uxin	Warrants Warrants	147895143
CY2022	uxin	Forward Contract ForwardContract	38191128
CY2021	uxin	Weighted Average Number Of Diluted Shares Outstanding Continuing Operations WeightedAverageNumberOfDilutedSharesOutstandingContinuingOperations	1100650208
CY2022	uxin	Weighted Average Number Of Diluted Shares Outstanding Continuing Operations WeightedAverageNumberOfDilutedSharesOutstandingContinuingOperations	1354506021
CY2023	uxin	Weighted Average Number Of Diluted Shares Outstanding Continuing Operations WeightedAverageNumberOfDilutedSharesOutstandingContinuingOperations	1344536565
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.65
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.07
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.66
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	230262825
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	245389524
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	923377527
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	76100000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	25800000
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	31700000
CY2023Q1	uxin	Appropriation To General Reserve Percentage Of Profit Net Of Tax AppropriationToGeneralReservePercentageOfProfitNetOfTax	0.10
CY2023Q1	uxin	Criteria For Appropriation To General Reserve Fund Maximum Threshold As Percentage Of Registered Capital CriteriaForAppropriationToGeneralReserveFundMaximumThresholdAsPercentageOfRegisteredCapital	0.50
CY2023	uxin	Appropriation Of Statutory Reserve Enterprise Expansion Fund And Staff Welfare And Bonus Fund AppropriationOfStatutoryReserveEnterpriseExpansionFundAndStaffWelfareAndBonusFund	0
CY2022	uxin	Appropriation Of Statutory Reserve Enterprise Expansion Fund And Staff Welfare And Bonus Fund AppropriationOfStatutoryReserveEnterpriseExpansionFundAndStaffWelfareAndBonusFund	0
CY2021	uxin	Appropriation Of Statutory Reserve Enterprise Expansion Fund And Staff Welfare And Bonus Fund AppropriationOfStatutoryReserveEnterpriseExpansionFundAndStaffWelfareAndBonusFund	0
CY2023Q1	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	0

Files In Submission

Name	View Source	Status
0000950170-23-042446-index-headers.html	Edgar Link	pending
0000950170-23-042446-index.html	Edgar Link	pending
0000950170-23-042446.txt	Edgar Link	pending
0000950170-23-042446-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img189347042_0.jpg	Edgar Link	pending
img191194084_0.jpg	Edgar Link	pending
img65561157_0.jpg	Edgar Link	pending
img65561157_1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uxin-20230331.htm	Edgar Link	pending
uxin-20230331.xsd	Edgar Link	pending
uxin-ex12_1.htm	Edgar Link	pending
uxin-ex12_2.htm	Edgar Link	pending
uxin-ex13_1.htm	Edgar Link	pending
uxin-ex13_2.htm	Edgar Link	pending
uxin-ex15_1.htm	Edgar Link	pending
uxin-ex15_2.htm	Edgar Link	pending
uxin-ex15_3.htm	Edgar Link	pending
uxin-ex15_4.htm	Edgar Link	pending
uxin-ex4_56.htm	Edgar Link	pending
uxin-ex4_57.htm	Edgar Link	pending
uxin-ex4_58.htm	Edgar Link	pending
uxin-ex4_59.htm	Edgar Link	pending
uxin-ex4_60.htm	Edgar Link	pending
uxin-ex8_1.htm	Edgar Link	pending
uxin-20230331_cal.xml	Edgar Link	unprocessable
uxin-20230331_def.xml	Edgar Link	unprocessable
uxin-20230331_lab.xml	Edgar Link	unprocessable
uxin-20230331_pre.xml	Edgar Link	unprocessable
uxin-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UXIN
Uxin Ltd Stock $uxin

2023 Q1 Form 20-F Financial Statement

#000095017023042446 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UXIN Uxin Ltd Stock $uxin

2023 Q1 Form 20-F Financial Statement

#000095017023042446 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UXIN
Uxin Ltd Stock $uxin